Identification of biomarkers that predict severity of COVID-19 patients

The outbreak of the new coronavirus in Wuhan, China has infected over 75,000 people and has caused close to 2,000 deaths. One of the major problems with this outbreak is that emergency rooms, hospitals and ICU wards are overwhelmed with patients. In an effort to find a test for rapidly determining who should be admitted to the hospital and who should be placed in the ICU, we have undertaken an international study to find a set of biomarkers that can be used to help Emergency Room doctors to make decisions on whether a patient will become severe. The researchers have established an international team based in China, Vietnam, Spain, Italy, Mozambique, Sudan, Ethiopia, Egypt, Morocco, Cote D’ Ivoire, and Canada. This team will examine patients peripheral blood for biomarkers that predict the course of the disease as mild or severe. The results of the study will be used to make a device that can be used in any situation and rapidly give results to predict the course of coronavirus infections.

Basic Science

Feb 2020 — Feb 2022

$1.19M

Canada
China
Côte d'Ivoire
Egypt
Ethiopia
Italy
Morocco
Mozambique
Spain
Sudan
Vietnam

Clinical Epidemiology of COVID-19 in Malaria Settings